RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+8.95%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$3B
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.3M |
| 2 |
Blackstone
BX
|
+$58.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$41.8M |
| 4 |
Palantir
PLTR
|
+$39.1M |
| 5 |
Snowflake
SNOW
|
+$25.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$217M |
| 2 |
Microsoft
MSFT
|
+$173M |
| 3 |
Linde
LIN
|
+$131M |
| 4 |
Amazon
AMZN
|
+$98M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$86.8M |
Sector Composition
| 1 | Technology | 23.36% |
| 2 | Financials | 14.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Shattuck Labs
STTK
$90.1M
| $673K | ﹤0.01% |
23,212
+9,967
| +75% | +$289K |
|
2427
Curis
CRIS
$22.6M
| $672K | ﹤0.01% |
+4,166
| New | +$672K |
|
|
ITOS
2428
DELISTED
iTeos Therapeutics
ITOS
| $671K | ﹤0.01% |
26,160
+7,594
| +41% | +$195K |
|
2429
Verastem
VSTM
$590M
| $665K | ﹤0.01% |
13,622
-3,148
| -19% | -$154K |
|
|
VLDR
2430
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $665K | ﹤0.01% |
+62,455
| New | +$665K |
|
2431
Coursera
COUR
$1.75B
| $651K | ﹤0.01% |
+16,445
| New | +$651K |
|
2432
Merchants Bancorp
MBIN
$1.46B
| $650K | ﹤0.01% |
24,861
-1,349
| -5% | -$35.3K |
|
|
SCU
2433
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $650K | ﹤0.01% |
26,421
+26
| +0.1% | +$640 |
|
|
MSP
2434
DELISTED
Datto Holding Corp.
MSP
| $650K | ﹤0.01% |
23,351
+3,110
| +15% | +$86.6K |
|
2435
REV Group
REVG
$3.13B
| $649K | ﹤0.01% |
41,341
-3,583
| -8% | -$56.2K |
|
|
SPNE
2436
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $649K | ﹤0.01% |
31,626
-5,623
| -15% | -$115K |
|
2437
National Research Corp
NRC
$369M
| $646K | ﹤0.01% |
14,067
-1,031
| -7% | -$47.3K |
|
|
XENT
2438
DELISTED
Intersect ENT, Inc
XENT
| $644K | ﹤0.01% |
37,654
-2,930
| -7% | -$50.1K |
|
|
ETWO
2439
DELISTED
E2open Parent Holdings
ETWO
| $643K | ﹤0.01% |
+56,297
| New | +$643K |
|
2440
Astronics
ATRO
$1.44B
| $641K | ﹤0.01% |
36,632
-2,736
| -7% | -$47.9K |
|
2441
Precigen
PGEN
$1.23B
| $641K | ﹤0.01% |
98,358
+8,597
| +10% | +$56K |
|
|
PRVB
2442
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $641K | ﹤0.01% |
76,077
+21,338
| +39% | +$180K |
|
|
IGMS
2443
DELISTED
IGM Biosciences
IGMS
| $640K | ﹤0.01% |
7,695
+40
| +0.5% | +$3.33K |
|
2444
Viking Therapeutics
VKTX
$2.9B
| $636K | ﹤0.01% |
106,150
-8,601
| -7% | -$51.5K |
|
|
VBIV
2445
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $636K | ﹤0.01% |
6,330
-574
| -8% | -$57.7K |
|
|
BFX
2446
DELISTED
BowFlex Inc.
BFX
| $636K | ﹤0.01% |
37,719
-8,557
| -18% | -$144K |
|
2447
Standard BioTools
LAB
$504M
| $635K | ﹤0.01% |
103,092
-10,201
| -9% | -$62.8K |
|
2448
Pliant Therapeutics
PLRX
$102M
| $634K | ﹤0.01% |
21,765
-2,282
| -9% | -$66.5K |
|
2449
Crinetics Pharmaceuticals
CRNX
$3.14B
| $632K | ﹤0.01% |
33,551
+5,154
| +18% | +$97.1K |
|
2450
Hovnanian Enterprises
HOV
$915M
| $632K | ﹤0.01% |
+5,946
| New | +$632K |
|